02504nas a2200361 4500000000100000008004100001260001300042653001000055653002600065653001100091653003400102653001100136653000900147653001600156653001000172653003800182653001500220653001600235653002100251653001900272653001700291653001700308100001500325700001400340700001400354700001500368700001200383245008000395300001000475490000600485520163700491022001402128 2000 d c2000 Aug10aAdult10aAntitubercular Agents10aFemale10aHealth Services Accessibility10aHumans10aMale10aMiddle Aged10aNepal10aPatient Acceptance of Health Care10aPharmacies10aPharmacists10aPrivate Practice10aPrivate Sector10aSocial Class10aTuberculosis1 aHurtig A K1 aPande S B1 aBaral S C1 aPorter J D1 aBam D S00aAnti-tuberculosis treatment in private pharmacies, Kathmandu Valley, Nepal. a730-60 v43 a

SETTING: Urban municipality of 150000 citizens in Kathmandu Valley, Nepal.

OBJECTIVE: To determine 1) the perceptions among private pharmacists of characteristics of tuberculosis (TB) patients visiting private pharmacies in the area, 2) the sales of different anti-tuberculosis drugs, and 3) the interaction between private health providers and pharmacists.

DESIGN: Between January and April 1998, semi-structured interviews were conducted with 98% (49/50) of the private drug-retailers in the area.

RESULTS: Thirty-two (65%) pharmacies had sold anti-TB drugs during the last month. Forty-three (88%) said that most TB patients were of low socio-economic status and rarely bought drugs for more than a week at a time. Only eight (16%) reported that TB patients usually returned to buy the full course of drugs. Seventy-two per cent of total spending on anti-tuberculosis drugs was for different kinds of combinations of drugs. Nine per cent was spent on plain rifampicin, believed to be sold only to tuberculosis/leprosy patients. During the previous month, 5/13 (38%) of pharmacies with no doctors attached had sold anti-tuberculosis drugs compared with 27/38 (71%) of pharmacies with doctors attached to them (P < 0.05).

CONCLUSION: The private sector offers an available and acceptable but non-affordable service for many TB patients. A substantial amount of anti-TB drugs are being sold in the private pharmacies. There is therefore a potential role for pharmacists to play in collaborative efforts between the private and public sector in TB control activities.

 a1027-3719